Asensus Surgical, Inc. Schedules Second Quarter Financial and Operating Results Conference Call for August 13, 2024
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company focused on digitizing surgeon-patient interfaces, has announced its plans to release 2024 second quarter financial and operating results after market close on Tuesday, August 13, 2024. The company will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide an update on the proposed merger with KARL STORZ.
Interested parties can access the call by dialing 1-800-717-1738 (domestic) or 1-646-307-1865 (international). A live audio webcast will also be available at https://ir.asensus.com/events-and-presentations, where a replay will be accessible after the call.
Asensus Surgical, Inc. (NYSE American: ASXC), una società di dispositivi medici focalizzata sulla digitalizzazione delle interfacce tra chirurghi e pazienti, ha annunciato i suoi piani per rilasciare i risultati finanziari e operativi del secondo trimestre 2024 dopo la chiusura del mercato il martedì 13 agosto 2024. L'azienda ospiterà una conferenza telefonica alle 16:30 ET dello stesso giorno per discutere di questi risultati e fornire un aggiornamento sulla fusione proposta con KARL STORZ.
Le parti interessate possono accedere alla chiamata componendo il numero 1-800-717-1738 (nazionale) o 1-646-307-1865 (internazionale). Sarà inoltre disponibile una diretta web audio su https://ir.asensus.com/events-and-presentations, dove sarà accessibile una registrazione dopo la chiamata.
Asensus Surgical, Inc. (NYSE American: ASXC), una compañía de dispositivos médicos centrada en la digitalización de las interfaces entre cirujanos y pacientes, ha anunciado sus planes para publicar los resultados financieros y operativos del segundo trimestre de 2024 después del cierre del mercado el martes 13 de agosto de 2024. La empresa realizará una llamada de conferencia a las 4:30 p.m. ET el mismo día para discutir estos resultados y proporcionar una actualización sobre la fusión propuesta con KARL STORZ.
Las partes interesadas pueden acceder a la llamada marcando el 1-800-717-1738 (nacional) o 1-646-307-1865 (internacional). También estará disponible una transmisión en vivo de audio en https://ir.asensus.com/events-and-presentations, donde después de la llamada se podrá acceder a una grabación.
Asensus Surgical, Inc. (NYSE American: ASXC)는 외과의사와 환자 간의 인터페이스 디지털화에 중점을 둔 의료 기기 회사로, 2024년 2분기 재무 및 운영 결과를 2024년 8월 13일 화요일 장 마감 이후 발표할 계획이라고 발표했습니다. 회사는 같은 날 오후 4시 30분 ET에 이러한 결과를 논의하고 KARL STORZ와의 제안된 합병에 대한 업데이트를 제공하기 위해 컨퍼런스 콜을 개최합니다.
관심 있는 분들은 1-800-717-1738 (국내) 또는 1-646-307-1865 (국제)로 전화를 통해 콜에 참여할 수 있습니다. 또한 https://ir.asensus.com/events-and-presentations에서 실시간 오디오 웹캐스트가 제공되며, 통화 이후 재생이 가능합니다.
Asensus Surgical, Inc. (NYSE American: ASXC), une entreprise de dispositifs médicaux axée sur la numérisation des interfaces entre chirurgiens et patients, a annoncé ses projets de publier les résultats financiers et opérationnels du deuxième trimestre 2024 après la fermeture du marché le mardi 13 août 2024. La société organisera une conférence téléphonique à 16h30 ET le même jour pour discuter de ces résultats et fournir une mise à jour sur la fusion proposée avec KARL STORZ.
Les parties intéressées peuvent accéder à l'appel en composant le 1-800-717-1738 (national) ou le 1-646-307-1865 (international). Un webinaire audio en direct sera également disponible sur https://ir.asensus.com/events-and-presentations, où une rediffusion sera accessible après l'appel.
Asensus Surgical, Inc. (NYSE American: ASXC), ein Medizintechnikunternehmen, das sich auf die Digitalisierung von Schnittstellen zwischen Chirurgen und Patienten konzentriert, hat angekündigt, seine finanziellen und betrieblichen Ergebnisse für das zweite Quartal 2024 nach Marktschluss am Dienstag, den 13. August 2024 bekannt zu geben. Das Unternehmen wird am selben Tag um 16:30 Uhr ET eine Telefonkonferenz veranstalten, um diese Ergebnisse zu diskutieren und ein Update zur vorgeschlagenen Fusion mit KARL STORZ zu geben.
Interessierte Parteien können an dem Anruf teilnehmen, indem sie 1-800-717-1738 (national) oder 1-646-307-1865 (international) wählen. Zudem wird eine Live-Audio-Webcast unter https://ir.asensus.com/events-and-presentations zur Verfügung stehen, wo nach dem Anruf eine Wiederholung zugänglich sein wird.
- Scheduled release of Q2 2024 financial results
- Upcoming investor conference call
- Potential merger with KARL STORZ to be discussed
- None.
RESEARCH TRIANGLE PARK, N.C., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient, announced today that it plans to release 2024 second quarter financial and operating results after the market closes on Tuesday, August 13, 2024. The Company will host a conference call to discuss these results and the status of the proposed merger with KARL STORZ starting at 4:30 p.m. ET the same day. The call will be concurrently webcast.
To listen to the conference call on your telephone, please dial 1-800-717-1738 for domestic
callers and 1-646-307-1865 for international callers, approximately ten minutes prior to the start time. To access the live audio webcast or archived recording, use the following link https://ir.asensus.com/events-and-presentations. The replay will be available on the Company’s website.
About Asensus Surgical, Inc.
Asensus Surgical is revolutionizing surgery with the first intra-operative Augmented Intelligence technology approved for use in operating rooms around the world. Recognized as an award-winning leader in digital technology, Asensus is committed to making surgery more accessible and predictable while delivering consistently superior outcomes. The Company’s novel approach to digitizing laparoscopy has led to system placements globally. Led by engineers, medical professionals, and industry luminaries, Asensus is powered by human ingenuity and driven by collaboration. To learn more about the Senhance® Surgical System and the new LUNA™ System in development, visit www.asensus.com.
Follow Asensus
Email Alerts: https://ir.asensus.com/email-alerts
LinkedIn: https://www.linkedin.com/company/asensus-surgical-inc/
X: https://twitter.com/AsensusSurgical
YouTube: https://www.youtube.com/@AsensusSurgical
INVESTOR CONTACT:
Mark Klausner or Mike Vallie
ICR Westwicke
invest@asensus.com
443-213-0499
MEDIA CONTACT:
Dan Ventresca
Matter Communications
AsensusPR@matternow.com
617-874-5488
FAQ
When will Asensus Surgical (ASXC) release its Q2 2024 financial results?
What time is Asensus Surgical's (ASXC) Q2 2024 earnings call scheduled for?
How can investors access Asensus Surgical's (ASXC) Q2 2024 earnings call?
What topics will be discussed in Asensus Surgical's (ASXC) upcoming earnings call?
